本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Tyra Biosciences, Inc.

35.13
-0.4350-1.22%
成交量:25.77萬
成交額:895.08萬
市值:18.92億
市盈率:-17.45
高:35.60
開:35.53
低:34.39
收:35.56
52周最高:40.65
52周最低:7.80
股本:5,386.71萬
流通股本:1,721.90萬
量比:0.77
換手率:1.50%
股息:- -
股息率:- -
每股收益(TTM):-2.0125
每股收益(LYR):-2.0125
淨資產收益率:-39.83%
總資產收益率:-25.68%
市淨率:7.30
市盈率(LYR):-17.45

資料載入中...

2026/04/17

重要事件披露

Form 8-K - Current report
2026/04/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/07

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/02

重要事件披露

Form 8-K - Current report
2026/03/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/04

重要事件披露

Form 8-K - Current report
2026/03/02

重要事件披露

Form 8-K - Current report
2026/03/02

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/01

重要事件披露

Form 8-K - Current report
2025/11/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]